| Source: Vistin Pharma ASA
Vistin Pharma ASA (OSE: VISTIN), please find attached the minutes from the annual general meeting held on 24 May 2017. All matters were resolved as proposed in the call for the annual general meeting.
For further information, please contact:
Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com
Oslo, Norway, 20 August 2026 Vistin Pharma ASA (VISTN) today announces its financial results for the second quarter and first half of 2026. Revenue in the second quarter amounted to MNOK 100,...
Read MoreOslo, Norway, 13 August 2026 Vistin Pharma ASA (VISTN) will release its second quarter and YTD 2026 results on Thursday 20th of August 2026. Vistin Pharma will host a conference call for all...
Read More